...
首页> 外文期刊>European journal of pharmaceutical sciences >Preparation of zolmitriptan-chitosan microparticles by spray drying for nasal delivery.
【24h】

Preparation of zolmitriptan-chitosan microparticles by spray drying for nasal delivery.

机译:通过喷雾干燥鼻腔给药制备佐米曲普坦-壳聚糖微粒。

获取原文
获取原文并翻译 | 示例
           

摘要

The objective of this study was to use spray drying to prepare mucoadhesive dry powders of the antimigraine drug, zolmitriptan, in combination with the natural polymer, chitosan, for nasal administration. The effect of type, molecular weight, and proportion of chitosan on the powder and particle characteristics was also studied. Solutions containing different proportions of chitosans were prepared and spray dried. The chemical stability and content of the drug were determined by HPLC. The morphology and size range of the microparticles were also determined. Solid-state analysis was undertaken using thermal methods (DSC/MDSC and TGA), powder X-ray diffraction (PXRD), and Fourier transform infra-red spectroscopy (FT-IR). The drug release profiles were investigated and the time required to reach maximum solution concentrations (T(max)) was used for comparison. The drug was chemically stable, with a 93-105% loading in the microparticles. The microparticles were spherical with a narrow size distribution, irrespective of the formulation. Phase separation was observed for formulations containing less than 90% (w/w) chitosan, irrespective of the type. In contrast, in the formulation containing 90% (w/w) chitosan, the drug was molecularly dispersed. FT-IR studies showed that the bands corresponding to intermolecular hydrogen bonding were broader and more diffuse when zolmitriptan was amorphous. The formation of a hydrogen bond between drug and chitosans was also observed. T(max) increased as the proportion of chitosan decreased, and was proportional to the molecular weight of the chitosan in the formulation containing 90% (w/w) chitosan. Spray drying is a suitable technique for making mucoadhesive dry powders of zolmitriptan and chitosan for nasal application. The dispersion and release of the drug was affected by the properties and composition of the chitosan.
机译:这项研究的目的是使用喷雾干燥来制备抗偏头痛药物佐米曲普坦与天然聚合物壳聚糖的粘膜粘附性干粉,用于鼻腔给药。还研究了壳聚糖的类型,分子量和比例对粉末和颗粒特性的影响。制备含有不同比例的壳聚糖的溶液并喷雾干燥。通过HPLC确定药物的化学稳定性和含量。还确定了微粒的形态和尺寸范围。使用热方法(DSC / MDSC和TGA),粉末X射线衍射(PXRD)和傅里叶变换红外光谱(FT-IR)进行了固态分析。研究了药物释放曲线,将达到最大溶液浓度(T(max))所需的时间用于比较。该药物化学稳定,微粒载量为93-105%。与制剂无关,微粒是具有狭窄尺寸分布的球形。对于包含小于90%(w / w)壳聚糖的制剂,无论其类型如何,都观察到相分离。相反,在含有90%(w / w)壳聚糖的制剂中,药物是分子分散的。 FT-IR研究表明,当佐米曲普坦为非晶态时,对应于分子间氢键的谱带更宽且更分散。还观察到药物和壳聚糖之间形成氢键。 T(max)随着壳聚糖比例的降低而增加,并且与含有90%(w / w)壳聚糖的配方中壳聚糖的分子量成正比。喷雾干燥是用于制备佐米曲普坦和脱乙酰壳多糖的鼻粘膜的粘膜粘附性干粉的合适技术。壳聚糖的性质和组成影响药物的分散和释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号